BackMarrone Bio Innovations Overview

Marrone Bio Innovations Long Term Debt

Latest long-term debt for MBII: $9.7M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$9.74M
↓ 54.89% YoYΔ $-11.86M vs prior year quarter

Peer trimmed avg / median

Loading

Marrone Bio Innovations Long Term Debt History

Loading

Marrone Bio Innovations vs. peers: Long Term Debt Comparison

Loading

Marrone Bio Innovations Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Marrone Bio Innovations (MBII) FAQ

As of the most recent data (March 2022), MBII shows a long-term debt of $9.7M. That compares with $22M in the prior-year period — down 54.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MBII's long-term debt is now $9.7M (was $22M) — a 54.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Marrone Bio Innovations is outperforming or lagging.

Tracking MBII's long-term debt over time shows whether Marrone Bio Innovations is scaling, shrinking, or reshaping that part of the business. The current reading is $9.7M That compares with $22M in the prior-year period — down 54.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Marrone Bio Innovations's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $9.7M) with ownership activity and broader fundamentals.

Marrone Bio Innovations's long-term debt is $9.7M; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.